Philip Johnson

Chief Financial Officer

CFO

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Jazz Pharmaceuticals plc (JAZZ)	Executive Vice President and CFO	$741,346	—	$6,046,903	—	$730,000	$26,224	$7,544,473
2024	Jazz Pharmaceuticals plc (JAZZ)	Executive Vice President and CFO	$581,539	$150,000	$4,063,313	—	$427,000	$21,593	$5,243,445

Executive changes

Appointed Executive Vice President and Chief Financial Officer at Jazz Pharmaceuticals plc (JAZZ)
2024-03-01

Earnings-call appearances

Jazz Pharmaceuticals plc Q1 FY2026 Earnings Call
Jazz Pharmaceuticals plc (JAZZ)

2026-05-05
Jazz Pharmaceuticals plc Q4 FY2025 Earnings Call
Jazz Pharmaceuticals plc (JAZZ)

2026-02-24
Jazz Pharmaceuticals plc Q3 FY2025 Earnings Call
Jazz Pharmaceuticals plc (JAZZ)

2025-11-05
Jazz Pharmaceuticals plc Q2 FY2025 Earnings Call
Jazz Pharmaceuticals plc (JAZZ)

2025-08-27
Jazz Pharmaceuticals plc Q1 FY2025 Earnings Call
Jazz Pharmaceuticals plc (JAZZ)

2025-05-06
Jazz Pharmaceuticals plc Q4 FY2024 Earnings Call
Jazz Pharmaceuticals plc (JAZZ)

2025-02-25
Jazz Pharmaceuticals plc Q3 FY2024 Earnings Call
Jazz Pharmaceuticals plc (JAZZ)

2024-11-06
Jazz Pharmaceuticals plc Q2 FY2024 Earnings Call
Jazz Pharmaceuticals plc (JAZZ)

2024-07-31
Jazz Pharmaceuticals plc Q1 FY2024 Earnings Call
Jazz Pharmaceuticals plc (JAZZ)

2024-05-01